Websterrogers Financial Advisors’s AbbVie ABBV Stock Holding History

Websterrogers Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$361K	Hold	1,433	–	–	0.09%	72
2026 Q1	$312K	Buy	1,433 +99	+7%	+$22K	0.09%	75
2025 Q4	$305K	Hold	1,334	–	–	0.09%	68
2025 Q3	$309K	Hold	1,334	–	–	0.09%	69
2025 Q2	$248K	Hold	1,334	–	–	0.08%	71
2025 Q1	$280K	Hold	1,334	–	–	0.1%	67
2024 Q4	$237K	Buy	1,334 +1	+0.1%	+$184	0.08%	72
2024 Q3	$263K	Hold	1,333	–	–	0.09%	62
2024 Q2	$229K	Hold	1,333	–	–	0.08%	63
2024 Q1	$243K	Hold	1,333	–	–	0.09%	68
2023 Q4	$207K	Buy	+1,333	New	+$194K	0.09%	71
2022 Q3	–	Sell	-1,396	Closed	-$214K	–	52
2022 Q2	$214K	Buy	1,396 +1	+0.1%	+$153	0.1%	56
2022 Q1	$227K	Buy	+1,395	New	+$203K	0.12%	61

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Websterrogers Financial Advisors's ABBV Position: Q2 2026 in Review

Websterrogers Financial Advisors held its AbbVie (ABBV) position steady in Q2 2026 at 1,433 shares worth $361K. The position accounts for 0.09% of the portfolio, ranked #72.

Websterrogers Financial Advisors first reported a position in ABBV in Q1 2022 and has held it in 13 quarters since. 835 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Websterrogers Financial Advisors held 1,433 shares of AbbVie worth $361K as of Q2 2026.
Websterrogers Financial Advisors left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.09% of Websterrogers Financial Advisors's portfolio in Q2 2026, its #72 holding.
Websterrogers Financial Advisors first reported a position in AbbVie in Q1 2022 and has held it in 13 quarters since.
835 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Websterrogers Financial Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.